A phase III randomised, double-blind, active-controlled parallel group efficacy and safety study of BI 10773 compared to glimepiride administered orally during 104 weeks in patients with type 2 diabetes mellitus and insufficient glycaemic control despite metformin treatment. Register Today!
Diabetes with Cardiovascular Risk
A Randomized, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study Of The Effects Of JNJ-28431754 On Cardiovascular Outcomes In Adult Subjects With Type 2 Diabetes Mellitus. Register Today!
Lauri Miller BA, CCRP
About Lauri Lauri began with Medicor in 2005 while finishing her Bachelor degree at Laurentian University. She had many roles at Medicor and saw many changes over the years as the company grew and matured. Her talent for negotiating surfaced early on when given the task of helping to finalize overdue contracts and budgets, she…
Marija Bernstein MSc., CCRP
About Marija Upon completion of her Bachelor of Life Sciences degree at Queen’s University in 2004, Marija went on to complete her Masters of Chemical Sciences degree in 2007. Marija then enjoyed a one year contract as a research assistant at Laurentian University working in the field of skeletal muscle plakins. Shifting her research focus…
Barbara Ward RPN, CCRP
About Barb Barb wears many hats at Medicor. She began her career in clinical research in 1996 and she says she got serious about clinical trials in 2005 when she incorporated Medicor. She has a background in both nursing and business and brings the two together to lead the company. She is passionate about helping…